Home » Topics » Disease categories and therapies » Infection

Infection
RSS

PathoGenesis in-licenses monobactam antibiotic from Bristol-Myers Squibb

Oct. 5, 1998

Genome Therapeutics and ArQule begin high-throughput screening

Oct. 5, 1998

Novavax presents BCTP, a novel antimicrobial nanoemulsion, at ICAAC

Oct. 2, 1998

L-084 selected for further development as oral carbapenem prodrug

Oct. 2, 1998

Pfizer presents a new macrolide that retains good activity in macrolide-resistant strains

Oct. 2, 1998

New echinocandin antifungal discovered by Fujisawa profiled up to phase I at ICAAC

Oct. 2, 1998

Inhibitors of bacterial protein identified at Cubist

Oct. 2, 1998

Xoma presents recombinant variant of rBPI21 with potent antiinfective activity

Oct. 2, 1998

Cubist and Novalon identify small-molecule inhibitors of bacterial enzyme

Oct. 2, 1998

Abbott uses TE-802 as lead to develop broader spectrum ketolides

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...